Retinal Imaging Study of Children That Might be at Risk of Having Retinal Hemorrhages

NCT ID: NCT05576285

Last Updated: 2023-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-08

Study Completion Date

2026-02-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a clinical trial in which we will learn about the retinal findings in three clinical groups of children, who might be at risk of having retinal hemorrhages (RH). The aim of the study is to explore the occurrence of moderate to severe retinal hemorrhages in critically ill children, children with intracranial hemorrhages, hydrocephalus or signs of elevated intracranial pressure and in children with benign enlargement of subarachnoid spaces (BESS).

1. Are RHs associated with BESS?
2. What is the prevalence, distribution and extent of RHs in critically ill children?
3. What is the prevalence, distribution and extent of RHs in children with traumatic brain injury?
4. Does the prevalence, distribution and extent of RHs differ in children with witnessed traumatic brain injury from children with traumatic brain injury of unknown origin?
5. To what extent do the causes of RHs affect visual acuity, initially and during recovery? A retinal ophthalmoscopy through dilated pupils will be conducted and a fundus photograph will be taken by a handheld, non-touch camera.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prospective study will take place at university hospitals in three Swedish regions, Stockholm, Skåne and Västra Götaland. The data collection from the three regions will proceed in parallel over a three-year period. An estimated number of children will be 400-500 per year. The study children will be consecutively referred to the pediatric ophthalmology units, where the ophthalmological examinations will take place. Bedside examinations will be performed when indicated at the pediatric intensive care units. Retinal fundus examination will be performed according to clinical standards following administration of pupil dilating eye drops in each eye. Visual function will be evaluated if ophthalmic abnormalities are detected.

Prospective observational study Group 1: All infants ≤ 18 months of age, who undergo neuroradiological examinations of the brain on the indication increased head circumference.

Group 2: All critically ill children \< 15 years of age, cared for at the hospitals, with neurological symptoms, that require neuroradiological examination of the brain.

Group 3: All children ≤ 2 years of age, who undergo emergency neuroradiological examinations of the head at the hospitals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Hemorrhage, Bilateral Retinal Hemorrhage, Left Eye Retinal Hemorrhage, Right Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Accelerating head growth in infancy

Infants \<=18 months of age referred to head ultrasound because of accelerating head growth

ophthalmoscopy and fundus photography through dilated pupills

Intervention Type DIAGNOSTIC_TEST

ophthalmoscopy and fundus photography through dilated pupills

Children at ICU with neurological symptoms that require brain MRI or CT

Children \< 15 years of age who are cared for at ICU becaus of neurological symptoms that require brain MRI or CT scans

ophthalmoscopy and fundus photography through dilated pupills

Intervention Type DIAGNOSTIC_TEST

ophthalmoscopy and fundus photography through dilated pupills

Children entering the emergency department with the need of acute brain CT

Children \< 2 years of age that enter the emergency department because of brainthreatening conditions that require acute brain CT scans

ophthalmoscopy and fundus photography through dilated pupills

Intervention Type DIAGNOSTIC_TEST

ophthalmoscopy and fundus photography through dilated pupills

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ophthalmoscopy and fundus photography through dilated pupills

ophthalmoscopy and fundus photography through dilated pupills

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants ≤ 18 months of age, who undergo neuroradiological examinations of the brain on the indication increased head circumference
* Children \< 15 years of age, cared for at the ICU, with neurological symptoms, that require neuroradiological examination of the brain
* Children \< 5 years of age, who undergo emergency neuroradiological examinations of the head at the hospitals

Exclusion Criteria

\- Infants with intraventricular hemorrhages due to prematurity, in the absence of increased head circumference
Minimum Eligible Age

4 Weeks

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Stockholm

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kerstin Hellgren

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kerstin M Hellgren, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Region Stockholm

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kerstin Margareta Hellgren

Stockholm, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hannamaria Öhnell, MD, PhD

Role: CONTACT

+4640-332781

Gunilla Magnusson, MD, PhD

Role: CONTACT

+4631- 343 32 56

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kerstin M Hellgren, MD, PhD

Role: primary

0734282124

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Dnr 2022-00506-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultra-low-dose Chest CT for HHT
NCT04874558 ACTIVE_NOT_RECRUITING